Cantor Fitzgerald Downgrades Tonix Pharma (TNXP) to Hold
Tweet
Share
E-mailGet Alerts TNXP Hot Sheet
Price: $12.55 --0%
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 4 | New: 41
Rating Summary:
6 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 4 | New: 41
Join SI Premium – FREE
Cantor Fitzgerald downgraded Tonix Pharma (NASDAQ: TNXP) from Buy to Hold with a price target of $1.00 (from $5.00).
For an analyst ratings summary and ratings history on Tonix Pharma click here. For more ratings news on Tonix Pharma click here.
Shares of Tonix Pharma closed at $0.92 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocMorris AG (DOCM:SW) PT Raised to CHF12.50 at Deutsche Bank
- UBS Downgrades Alkane Resources (ALK:AU) to Neutral
- Barclays Downgrades Shurgard Self Storage SA (SHUR:BB) to Underweight
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
